Hillstream Biopharma Inc.

HILS
Date Form Type SEC Filings
Oct 10, 2024 4 Profile Financial Statements
Oct 9, 2024 4/A Profile Financial Statements
Oct 8, 2024 4 Profile Financial Statements
Sep 30, 2024 8-K Profile Financial Statements
Sep 16, 2024 8-K Profile Financial Statements
Aug 12, 2024 4 Profile Financial Statements
Aug 9, 2024 10-Q Profile Financial Statements
Jul 23, 2024 424B3 Profile Financial Statements
Jul 19, 2024 EFFECT Profile Financial Statements
Jul 15, 2024 S-3 Profile Financial Statements
Jun 28, 2024 D Profile Financial Statements
Jun 7, 2024 8-K Profile Financial Statements
Jun 7, 2024 424B5 Profile Financial Statements
May 9, 2024 10-Q Profile Financial Statements
Mar 22, 2024 DEFA14A Profile Financial Statements
Mar 22, 2024 ARS Profile Financial Statements
Mar 21, 2024 DEFA14A Profile Financial Statements
Mar 21, 2024 DEF 14A Profile Financial Statements
Dec 18, 2023 4 Profile Financial Statements
Dec 11, 2023 8-K/A Profile Financial Statements
Dec 8, 2023 8-K Profile Financial Statements
Dec 7, 2023 8-K Profile Financial Statements
Nov 29, 2023 424B5 Profile Financial Statements
Nov 27, 2023 EFFECT Profile Financial Statements
Nov 27, 2023 8-K Profile Financial Statements
Nov 17, 2023 FWP Profile Financial Statements
Nov 9, 2023 4 Profile Financial Statements
Nov 7, 2023 DEL AM Profile Financial Statements
Nov 7, 2023 10-Q Profile Financial Statements
Nov 6, 2023 S-1 Profile Financial Statements
Oct 24, 2023 8-K Profile Financial Statements
Sep 29, 2023 DEFA14A Profile Financial Statements
Sep 25, 2023 8-K Profile Financial Statements
Sep 12, 2023 8-K Profile Financial Statements
Aug 30, 2023 DEFA14A Profile Financial Statements
Aug 30, 2023 DEF 14A Profile Financial Statements
Aug 18, 2023 PRE 14A Profile Financial Statements
Aug 11, 2023 10-Q Profile Financial Statements
Jul 17, 2023 8-K Profile Financial Statements
Jul 11, 2023 8-K Profile Financial Statements
Jun 20, 2023 8-K Profile Financial Statements
Mar 16, 2023 10-K Profile Financial Statements
Apr 1, 2022 10-K Profile Financial Statements